Program

PDF Program Download

12:00-13:00   Registration
13:00-14:30   Session I: Trauma and Headache
Chair: Antonella Palla, Zurich
13:00-13:05   Welcome
Antonella Palla, Zurich
13:05-13:50   Keynote: Post-traumatic headache
Henrik Winther Schytz, Glostrup, DK
13:50-14:15   Headache after head trauma: neuropsychiatric perspectives over the lifespan
Katrin Rauen, Zurich
14:15-14:30   Tricky Trauma Case 
Stephan Ulmer, Feldmeilen
Commented by Henrik Winther Schytz
14:30-15:40   Coffee Break | Exhibition
14:35-15:35   Industry Flash Session
What's New?
Moderation: Andreas R. Gantenbein, Bad Zurzach
14:35-14:50   TEVA PHARMA AG
Switching between aCGRP mAbs - Real-World Update at its FINESSEt
Christoph Schankin, Berne
14:50-15:05   NOVARTIS PHARMA SCHWEIZ AG
Time to press pause: First prospective Swiss real-world data of the impact of a temporary interruption of a CGRP treatment (erenumab)
Chiara Zecca, Lugano
15:05-15:20   LUNDBECK (SCHWEIZ) AG
Eptinezumab for the preventive treatment of migraine - Clinical evidence and practical considerations
Gabrielle Di Virgilio, Rennaz
15:20-15:35   ELI LILLY (SUISSE) SA
Galcanezumab helps address patients unmet needs in migraine prevention
Athina Papadopoulou, Basel
14:30-15:40   Coffee Break | Exhibition
15:40-17:10   Session II: Cluster Headache and other TAC
Chair: Andreas Kleinschmidt, Geneva
15:40-16:25   Keynote: Cluster Headache
Anish Bahra, London, UK
16:25-16:50   Launching a Swiss TAC Headache registry
Heiko Pohl, Zurich
16:50-17:05   Tricky TAC Case
Antonia Klein, Berne
Commented by Anish Bahra
17:05-17:10   Closure & Farewell
Andreas Kleinschmidt, Geneva
17:10-18:00   Apéro | Exhibition